Skip to main content

Table 3 Best performing single and double sampling strategies for estimation of AUC0-12 of MPA

From: Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis

(A) Bayesian estimator

Sampling points

r2

p

MPE (%)

95% LLCI

95% ULCI

RMSPE (%)

C4

0.713

 < 0.001

-6.53

-15.23

2.18

25.04

C8

0.746

 < 0.001

-2.58

-9.99

4.84

20.75

C0

0.754

 < 0.001

-11.86

-18.23

-5.48

21.30

C6

0.769

 < 0.001

-0.72

-7.51

6.08

18.89

C6, C12

0.851

 < 0.001

-2.46

-8.72

3.80

17.56

C6, C8

0.854

 < 0.001

0.15

-5.38

5.69

15.36

C1, C3

0.860

 < 0.001

-10.49

-16.72

-4.25

20.25

C1, C4

0.883

 < 0.001

-12.83

-18.43

-7.22

20.17

(B) Linear regression

Model equation

r2

p

MPE (%)

95% LLCI

95% ULCI

RMSPE (%)

AUC0-12 = 11.2C0 + 31.6

0.654

 < 0.001

7.66

-1.98

17.29

27.83

AUC0-12 = 11.4C8 + 21.8

0.679

 < 0.001

7.10

-2.89

17.09

28.63

AUC0-12 = 8.3C6 + 26.8

0.695

 < 0.001

6.66

-2.86

16.18

27.26

AUC0-12 = 10.6C4 + 21.5

0.702

 < 0.001

6.06

-3.53

15.65

27.32

AUC0-12 = 6.5C0 + 6.9C4 + 18.9

0.837

 < 0.001

4.03

-3.46

11.53

21.20

AUC0-12 = 5.2C6 + 6.8C8 + 16.8

0.840

 < 0.001

4.12

-2.75

10.99

19.53

AUC0-12 = 1.4C1 + 9.2C8 + 9.2

0.844

 < 0.001

4.85

-2.30

12.00

20.43

AUC0-12 = 1.4C1 + 8.7C4 + 7.8

0.885

 < 0.001

2.50

-2.74

7.73

14.75

  1. 95% LLCI lower limit of the 95% confidence interval of MPE, 95% ULCI upper limit of the 95% confidence interval of MPE, MPE mean prediction error, RMSPE root mean squared percentage error